Noelle E Carlozzi1, Rebecca E Ready2, Samuel Frank3, David Cella4,5, Elizabeth A Hahn5, Siera M Goodnight1, Stephen G Schilling1,6, Nicholas R Boileau1, Praveen Dayalu7. 1. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA. 2. Department of Psychological and Brain Sciences, University of Massachusetts, Amherst, Massachusetts, USA. 3. Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 4. Institute for Health Services Research & Policy Studies, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. 5. Department of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA. 6. Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA. 7. Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Abstract
BACKGROUND: There is a need for patient-reported outcome measures that capture the impact that motor impairments have on health-related quality of life in individuals with Huntington's disease. OBJECTIVES: The objectives of this study were to establish the reliability and validity of new physical functioning patient-reported outcome measures in Huntington's disease. METHODS: A total of 510 individuals with Huntington's disease completed 2 Quality of Life in Neurological Disorders (Lower Extremity Function and Upper Extremity Function) and 3 Huntington's Disease Health-Related Quality of Life (Chorea, Speech Difficulties, and Swallowing Difficulties) measures. Clinician-rated and generic self-report measures were also administered. RESULTS: Reliabilities for the new patient reported physical functioning measures were excellent (all Cronbach's α > .92). Convergent, discriminant validity and known group validity was supported. CONCLUSIONS: The results provide psychometric support for new patient-reported physical functioning measures and the fact that these measures can be used as clinically meaningful endpoints in Huntington's disease research and clinical practice.
BACKGROUND: There is a need for patient-reported outcome measures that capture the impact that motor impairments have on health-related quality of life in individuals with Huntington's disease. OBJECTIVES: The objectives of this study were to establish the reliability and validity of new physical functioning patient-reported outcome measures in Huntington's disease. METHODS: A total of 510 individuals with Huntington's disease completed 2 Quality of Life in Neurological Disorders (Lower Extremity Function and Upper Extremity Function) and 3 Huntington's Disease Health-Related Quality of Life (Chorea, Speech Difficulties, and Swallowing Difficulties) measures. Clinician-rated and generic self-report measures were also administered. RESULTS: Reliabilities for the new patient reported physical functioning measures were excellent (all Cronbach's α > .92). Convergent, discriminant validity and known group validity was supported. CONCLUSIONS: The results provide psychometric support for new patient-reported physical functioning measures and the fact that these measures can be used as clinically meaningful endpoints in Huntington's disease research and clinical practice.
Authors: Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn Journal: Lancet Neurol Date: 2011-12-02 Impact factor: 44.182
Authors: K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington Journal: Neurology Date: 2010-07-07 Impact factor: 9.910
Authors: Sarah J Tabrizi; Rachael I Scahill; Alexandra Durr; Raymund Ac Roos; Blair R Leavitt; Rebecca Jones; G Bernhard Landwehrmeyer; Nick C Fox; Hans Johnson; Stephen L Hicks; Christopher Kennard; David Craufurd; Chris Frost; Douglas R Langbehn; Ralf Reilmann; Julie C Stout Journal: Lancet Neurol Date: 2010-12-02 Impact factor: 44.182
Authors: N E Carlozzi; N R Downing; S G Schilling; J-S Lai; S M Goodnight; J A Miner; S A Frank Journal: Qual Life Res Date: 2016-05-03 Impact factor: 4.147
Authors: N E Carlozzi; S G Schilling; J-S Lai; J S Perlmutter; M A Nance; J F Waljee; J A Miner; S K Barton; S M Goodnight; P Dayalu Journal: Qual Life Res Date: 2016-04-01 Impact factor: 4.147
Authors: D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy Journal: Neurology Date: 2012-05-09 Impact factor: 9.910
Authors: Monica Busse; Lori Quinn; Helen Dawes; Carys Jones; Mark Kelson; Vincent Poile; Rob Trubey; Julia Townson; Rhiannon Tudor Edwards; Anne Rosser; Kerenza Hood Journal: Trials Date: 2014-12-12 Impact factor: 2.728
Authors: Noelle E Carlozzi; Nicholas R Boileau; Kelvin L Chou; Rebecca E Ready; David Cella; Michael K McCormack; Jennifer A Miner; Praveen Dayalu Journal: Mov Disord Date: 2019-11-14 Impact factor: 10.338
Authors: Noelle E Carlozzi; Nicholas R Boileau; Angela Roberts; Praveen Dayalu; Dana L Hanifan; Jennifer A Miner; Daniel Claassen; Emily Mower Provost Journal: Qual Life Res Date: 2020-08-24 Impact factor: 4.147
Authors: Eileen Mack Thorley; Ravi G Iyer; Paul Wicks; Chris Curran; Sanjay K Gandhi; Victor Abler; Karen E Anderson; Noelle E Carlozzi Journal: Patient Date: 2018-10 Impact factor: 3.883
Authors: Leonard L Sokol; Jonathan P Troost; Benzi M Kluger; Allison J Applebaum; Jane S Paulsen; Danny Bega; Samuel Frank; Joshua M Hauser; Nicholas R Boileau; Colin A Depp; David Cella; Noelle E Carlozzi Journal: Ann Clin Transl Neurol Date: 2021-07-20 Impact factor: 4.511